[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370361-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370361-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","informing-implementation-strategies-for-pharmacogenomics-in-cancer-development-of-survey-tools-for-healthcare-professionals-and-consumers","Informing Implementation Strategies for Pharmacogenomics in Cancer - Development of Survey Tools for Healthcare Professionals and Consumers","","Integration of clinical pharmacogenomics (PGx) into routine cancer care remains limited despite widespread use of PGx-impacted medicines, evidence supporting PGx benefits, and the existence of international clinical guidelines. The study developed survey tools to assess PGx knowledge, attitudes, practices, perceptions, and education needs among healthcare professionals and consumers. Tools were created using a three-phase mixed-methods approach with literature-informed content, priority partnership refinement, and content/face validity plus health-literacy assessments.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/informing-implementation-strategies-for-pharmacogenomics-in-cancer-development-of-survey-tools-for-healthcare-professionals-and-consumers/370361/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/informing-implementation-strategies-for-pharmacogenomics-in-cancer-development-of-survey-tools-for-healthcare-professionals-and-consumers/370361.png","ImageObject",300,407,{"name":42,"@type":43},"Riley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are implementation strategies for pharmacogenomics needed in cancer care?","Question",{"text":63,"@type":64},"Clinical PGx integration into routine cancer care is limited, and there are currently no tools to assess local implementation requirements. Locally contextual enablers and barriers are implied by the uneven uptake across centers or regions.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Who are the survey tools designed for?",{"text":68,"@type":64},"Two tool versions were developed: one for healthcare professionals (doctors, nurses, pharmacists) involved in cancer care, and another for consumers (adults who received cancer treatment or their carers).",{"name":70,"@type":61,"acceptedAnswer":71},"How were the survey tools developed and refined?",{"text":72,"@type":64},"The tools were built using a three-phase mixed-methods approach. Content was informed by a systematic literature review, framed by determinants of behavior via the Theoretical Domains Framework, refined through priority partnership meetings, and finalized using content/face validity and health-literacy assessments.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370361,1790328928,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":106,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Clinical and Translational Science   \n CLINICAL TRIAL IN PROGRESS  OPEN ACCESS   \nInforming Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers  \nMarliese Alexander1,2  | Chiao Xin Lim3,4  | Senthil Lingaratnam1,2  | Sarah Glewis1,2  | Joanne Wickens3  | Abbey Hird3 | Zi Yue Chen3 | Alistair Bozkurt3  | Amit Khot2,5  | David Routledge2,5  | Sam Harris6 |  \nCraig Underhill7,8,9  | Ashley Whitechurch5  | Lydia Leong1 | Marcus Pergolini1 | Gail Rowan1 | Monnette Samo1 | Chloe Georgiou6 | Peter Savas2,10  | Jenny Devine11,12 | Alysia Kepert12 | Safeera Y. Hussainy1,2,13   \n1Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia | 2Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia | 3Pharmacy, School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia | 4Medicine Department, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia | 5Clinical Haematology Department, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia | 6Bendigo Cancer Centre, Bendigo Health, Bendigo, Victoria, Australia | 7Border Medical Oncology Research Unit, Albury Wodonga Regional Cancer Centre, Albury, New South Wales, Australia | 8Victorian Comprehensive Cancer Centre Alliance, Melbourne, Victoria, Australia | 9University of NSW Rural Medical School, Albury, New South Wales,  \nAustralia | 10Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia | 11Alcohol and Other Drugs Committee, The Royal Australian College of General Practitioners, Melbourne, Victoria, Australia | 12Consumer Representative, Peter MacCallum Cancer Centre,  \nMelbourne, Victoria, Australia | 13Department of General Practice, School of Public Health and Preventive Medicine, Monash University, Victoria, Australia Correspondence: Marliese Alexander ([marliese.alexander@unimelb.edu.au](marliese.alexander@unimelb.edu.au))  \nReceived: 17 November 2024 | Revised: 22 December 2024 | Accepted: 15 January 2025  \nFunding: This research was undertaken under a program funded by the Australian Medical Research Future Fund Quality, Safety and Effectiveness of  \nMedicine Use by Pharmacists (grant ID: MRFMMIP000011, CIA M Alexander) .  \nKeywords: cancer | consumers | health professionals | pharmacogenomics | survey  \nABSTRACT  \nIntegration of clinical pharmacogenomics (PGx) within routine cancer care is limited despite frequent use of medicines impacted by PGx, evidence for the benefits of PGx, and the availability of international PGx clinical guidelines. Our study objective was to develop survey tools to assess PGx knowledge, attitudes, practices, perceptions, and education needs among (a) doctors, nurses, and pharmacists involved in cancer care (healthcare professionals, HCPs) and (b) adults who have received cancer treatment or their carers (consumers), with the view to informing implementation strategies for PGx in solid and hematologic cancers. Survey tools were developed in a three-phase (ph) mixed-methods approach. Content was informed by systematic literature review findings and framed by determinants of behavior as informed by the Theoretical Domains Framework (ph-1) . Refinement occurred through four separate priority partnership meetings (ph-2) . Meetings focused on clinical PGx practices within select cancer streams, and consumers' knowledge, attitudes, and preferences for PGx testing. Content/face validity and health literacy (Flesch Kincaid Grade Level) assessments informed final refinements (ph-3) . Separate HCP and consumer survey tools were developed with six common sections: (1) introduction; (2) demographics; (3) experience; (4) knowledge, attitudes, practices and perceptions; (5) education; and (6) vignettes. Content and face validity were rated highly with acceptable health literacy assessments for quest","cbCaij1kcwOzLYgn","https://ap.wps.com/l/cbCaij1kcwOzLYgn","pdf",377766,"English","# Abstract\n## Summary of key questions\n## What this study addressed\n## What this study adds\n## How it may affect clinical pharmacology or translational science","[{\"question\":\"Why are implementation strategies for pharmacogenomics needed in cancer care?\",\"answer\":\"Clinical PGx integration into routine cancer care is limited, and there are currently no tools to assess local implementation requirements. Locally contextual enablers and barriers are implied by the uneven uptake across centers or regions.\"},{\"question\":\"Who are the survey tools designed for?\",\"answer\":\"Two tool versions were developed: one for healthcare professionals (doctors, nurses, pharmacists) involved in cancer care, and another for consumers (adults who received cancer treatment or their carers).\"},{\"question\":\"How were the survey tools developed and refined?\",\"answer\":\"The tools were built using a three-phase mixed-methods approach. Content was informed by a systematic literature review, framed by determinants of behavior via the Theoretical Domains Framework, refined through priority partnership meetings, and finalized using content/face validity and health-literacy assessments.\"}]","Informing Implementation Strategies for Pharmacogenomics in Cancer - Development of Survey Tools for Healthcare Professionals and Consumers | PDF",1790188173,18,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9de1d9af1475fda971932081c570c39.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee0edb96b66a98cb4d8c431b7f0870d2.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14e0989f65e2bcb16f2a3f5cbb645c52.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e093e0cf9794bc5f9fc37f002cf410f.webp",980,1287]